Clinical Trial

Effects of Paraxanthine Supplementation on eSport Performancre

Study acronym: EPX
Completed
View on ClinicalTrials.gov →
Summary
This study will evaluate the effects of daily paraxanthine supplementation on electronic gaming performance, cognitive function, sleep quality, and autonomic responses in healthy adult gamers. Participants will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group study and assigned to receive either paraxanthine or placebo daily for 6 weeks. Outcome measures will be assessed at baseline, Week 3, and Week 6 and will include electronic gaming performance, cognitive function, visual analog scale ratings, sleep quality questionnaires, hemodynamic responses, and heart rate variability. The study is designed to determine whether paraxanthine supplementation improves performance and selected physiological and psychological outcomes during prolonged electronic gaming sessions.
Trial Details
NCT Number NCT07533045
Lead Sponsor Lindenwood University
Conditions Cognitive Function, Gaming Performance
Enrollment 60 participants
Start Date 2021-06-15
Primary Completion 2025-04-14 (estimated)
Study Completion 2025-04-14 (estimated)
Updated on ClinicalTrials.gov 2026-04-16